Programmed cell death and Parkinson's disease

Movement Disorders

Volumn 13, Issue SUPPL. 1, 1998, Pages 17-23

  Burke, Robert E ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; DOPAMINE; GENE EXPRESSION; HUMANS; NEURONS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 0031898760     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (70)

1. Petite CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995;146:1121-1130.
2. Nitatori T, Sato N, Waguri S, et al. Delayed neuronal death in the CA 1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 1995;15:1001-1011.
3. Glucksmann A. Cell deaths in normal vertebrate ontogeny. Biol Rev 1951;26:59-86.
4. Hamburger V. History of the discovery of neuronal death in embryos. J Neurobiol 1992;23:1116-1123.
5. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
6. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991;14:453-501.
7. Ellis RE, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol 1991;7:663-698.
8. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/ CED-3 protease nomenclature. Cell 1996;87:171.
9. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell 1995;82:349-352.
10. Korsmeyer SJ. Regulators of cell death. Trends Genet 1995;11: 101-105.
11. Martin DP, Schmidt RE, DiStefano P, Lowry O, Carter J, Johnson E. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 1988;106:829-844.
12. Oppenheim RW, Frevelte D, Tytell M, Homma S. Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes. Dev Biol 1990;138:104-113.
13. Clarke PGH. Developmental cell death: morphological diversity and multiple mechanisms. Anal Embryol (Berl) 1990;181:195-213.
14. Schwartz LM, Smith SW, Jones MEE, Osborne BA. Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 1993;90:980-984.
15. Pilar G, Landmesser L. Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia. J Cell Biol 1976;68:339-356.
16. Kerr JFR, Gobe GC, Winterford CM, Harmon BV. Anatomical methods in cell death. In: Schwartz LM, Osborne BA, eds. Methods in cell biology: cell death. New York, NY: Academic Press, 1995:1-27.
17. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
18. Grasl-Kraupp B, Ruttkay-Ndicky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995;21:1465-1468.
19. Ferrer I, Tortosa A, Macaya A, et al. Evidence of nuclear DNA fragmentation following hypoxia-ischemia in the infant rat brain, and transient forebrain ischemia in the adult gerbil. Brain Pathol 1994;4:115-122.
20. Oo TF, Henchcliffe C, Burke RE. Apoptosis in substantia nigra following developmental hypoxic-ischemic injury. Neuroscience 1995;69:893-901.
21. Burke RE, Macaya A, DeVivo D, Kenyon N, Janec EM. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons. Neuroscience 1992;50:559-569.
22. Macaya A, Burke RE. Effect of striatal lesion with quinolinate on the development of substantia nigra dopaminergic neurons: a quantitative morphological analysis. Dev Neurosci 1992;14:362-368.
23. Prochiantz A, di Porzio U, Kato A, Berger B, Glowinski J. In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc Natl Acad Sci USA 1979;76:5387-5391.
24. Hemmendinger LM, Garber BB, Hoffmann PC, Heller A. Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro. Proc Natl Acad Sci USA 1981;78: 1264-1268.
25. Hoffmann PC, Hemmendinger LM, Kotake C, Heller A. Enhanced dopamine cell survival in reaggregates containing target cells. Brain Res 1983;274:275-281.
26. Tomozawa Y, Appel SH. Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro. Brain Res 1986;399:111-124.
27. Barde YA. Trophic factors and neuronal survival. Neuron 1989;2: 1525-1534.
28. Clarke PGH. Neuronal death in the development of the vertebrate nervous system. Trends Neurosci 1985;8:345-349.
29. Janec E, Burke RE. Naturally occurring cell death during postnatal development of the substantia nigra of the rat. Mol Cell Neurosci 1993;4:30-35.
30. Oo TF, Burke RE. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Dev Brain Res 1997;98:191-196.
31. Tepper JM, Damlama M, Trent F. Postnatal changes in the distribution and morphology of rat substantia nigra dopaminergic neurons. Neuroscience 1994;60:469-177.
32. Macaya A, Munell F, Gubits RM, Burke RE. Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc Natl Acad Sci USA 1994;91:8117-8121.
33. Kelly WJ, Burke RE. Apoptotic neuron death in rat substantia nigra induced by striatal excitotoxic injury is developmentally dependent. Neurosci Lett 1996;220:85-88.
34. Lindsay RM. Brain-derived neurotrophic factor: an NGF-related neurotrophin. In: Loughlin SE, Fallon JH, eds. Neurotrophic factors. San Diego, CA: Academic Press, 1993:257-284.
35. Marti MJ, James CJ, Oo TF, Kelly WJ, Burke RE. Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J Neurosci 1997; 17:2030-2039.
36. Cunningham TJ. Naturally occurring neuron death and its regulation by developing neural pathways. Int Rev Cytol 1982;74:163-186.
37. Walkinshaw G, Waters CM. Neurotoxin induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 1994;63:975-987.
38. Jeon BS, Jackson-Lewis V, Burke RE. 6-hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration 1995;4:131-137.
39. Dipasquale B, Marini AM, Youle RJ. Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Comm 1991;181:1442-1448.
40. Mochizuki H, Nakamura N, Nishi K, Mizuno Y. Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic striatal co-culture in rat. Neurosci Lett 1994;170: 191-194.
41. Mutoh T, Tokuda A, Marini AM, Fujiki N. 1-methyl-4-phenyl-pyridinum kills differentiated PC12 cells with a concomitant change in protein phosphorylation. Brain Res 1994;661:51-55.
42. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AHV. Complex I inhibitors induce dose dependent apoptosis in PC12 cells relevance to Parkinson's disease. J Neurochem 1994;63:1987-1990.
43. Itano Y, Nomura Y. 1-methyl-4-phenyl-pyridinium ion (MPP[+]) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells, through different mechanisms. Brain Res 1995;704:240-245.
44. Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 1995;4:257-269.
45. Tatton NA, Kish SJ. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange. Neuroscience 1997;77: 1037-1048.
46. Hassouna I, Wickert H, Zimmermann M, Gillardon F. Increase in bax expression in substantia-nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice. Neurosci Lett 1996;204:85-88.
47. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
48. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Bcl-2/ Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993;4:327-332.
49. Trimmer PA, Smith TS, Jung AB, Bennett JP Jr. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration 1996;5:233-239.
50. Lane DP, Lu X, Hupp T, Hall PA. The role of p53 protein in the apoptotic response. Philos Trans R Soc Lond B Biol Sci 1994;345: 277-280.
51. Yonish-Rouach E, Gninwald D, Wilder S, et al. p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol 1993;13: 1415-1423.
52. Chopp M, Li Y, Zhang ZG, Freytag SO. p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem Biophys Res Comm 1992;182:1201-1207.
53. Smeyne RJ, Goldowitz D. Development and death of external granular layer cells in the weaver mouse cerebellum: a quantitative study. J Neurosci 1989;9:1608-1620.
54. Migheli A, Attanasio A, Lee W-H, Bayer SA, Ghetti B. Detection of apoptosis in weaver cerebellum by electron microscopic in situ end-labeling of fragmented DNA. Neurosci Lett 1995;199:53-56.
55. Wullner U, Loschmann PA, Weller M, Klockgether T. Apoptotic cell death in the cerebellum of mutant weaver and lurcher mice. Neurosci Lett 1995;200:109-112.
56. Harrison SMW, Roffler-Tarlov S. Apoptotic and non-apoptotic cell death in the mouse mutant weaver [Abstract]. Soc Neurosci Abstr 1995;424:16.
57. Oo TF, Blazeski R, Harrison SMW, et al. Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic. J Neurosci 1996;16:6134-6145.
58. Anglade P, Vyas S, Javoy-Agid F, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 1997;12:25-31.
59. Mochizuki H, Goto K, Mori H, Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 1996;137:120-123.
60. Tompkins MM, Basgall EJ, Zamrini E, Hill WD. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am J Pathol 1997;150:119-131.
61. Kosel S, Egensperger R, von Eitzen U, Mehraein P, Graeber MB. On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol (Berl) 1997;93:105-108.
62. Lindvall O, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. Arch Neurol 1989;46:615-631.
63. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990;247:574-577.
64. Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994;35:172-180.
65. Yurek DM, Sladek JR. Dopamine cell replacement: Parkinson's disease. Annu Rev Neurosci 1990;13:415-440.
66. Mahalik TJ, Hahn WE, Clayton GH, Owens GP. Programmed cell death in developing grafts of fetal substantia nigra. Exp Neurol 1994;129:27-36.
67. Zastrow DJ, Zawada WM, Clarkson ED, Adams F, Bell P, Freed CR. Preincubation with growth factors improves survival of early mesencephalic grafts in hemiparkinsonian rats [Abstract]. Society for Neuroscience Abstracts 1996;22:1493.
68. Fahn S. Controversies in the therapy of Parkinson's disease. In: Battistin L, Scarlato G, Caraceni T, Ruggieri S, eds. Advances in neurology, Vol 69: Parkinson's disease. Philadelphia, PA: Lippincott Raven, 1996:477-486.
69. Ziv I, Melamed E, Nardi N, et al. Dopamine induces apoptosis like cell death in cultured chick sympathetic neurons: a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci Lett 1994;170:136-140.
70. Walkinshaw G, Waters CM. Induction of apoptosis in catecholaminergic PC12 cells by L-dopa. J Clin Invest 1995;95:2458-2464.